Individuals who have had multiple COVID-19 infections appear prone to contracting long COVID, which may include symptoms such as fatigue, respiratory distress, and mental fog.
Individuals who have had multiple COVID-19 infections appear prone to contracting long COVID, which may include symptoms such as fatigue, respiratory distress, and mental fog.
Read More
New research suggests COVID-19 infection may lead to cases of a chronic condition, resembling but diagnostically separate from long COVID, characterized by persistent fatigue and post-exertional malaise.
Read More
An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long-COVID.
Read More
While infections are often linked to increased disability in people with MS, a new study shows that COVID-19 does not worsen symptoms or disability.
Read More
High-quality face masks, such as N95/FFP2, can lower the risk of COVID-19 transmission by up to nine times when used by the entire UK population and by three times with individual use, according to a new study.
Read More
A therapeutic dose of anticoagulation with herapins also reduced the need for mechanical ventilation and the risk of thromboembolic events.Â
Read More
New findings suggest long COVID exacerbates financial instability for Americans, with low-income groups bearing the brunt.
Read More
The transcutaneous electrical nerve stimulation device “offered immediate, on-demand relief,” say researchers.
Read More
A study using lung and brain MRI shows that lower pulmonary gas exchange in long COVID patients is linked to cognitive dysfunction.
Read More
A new study from Northwestern Medicine finds symptoms occurred regardless of mild or severe COVID-19 infection.
Read More
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the developing fetus for 66% of pregnancies.
Read More
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Read More
The COVID-19 pandemic led to a noticeable rise in sepsis-related hospitalizations, hospital costs, and in-hospital mortality, particularly for patients with a COVID-19 diagnosis.
Read More
A new study reveals that immune cells, typically involved in lung repair, may instead drive persistent damage and fibrosis in COVID patients, preventing proper healing.
Read More
Future updates to COVID-19 treatment recommendations will transition to professional medical societies.
Read More
Recovering from COVID-19 may strengthen the immune system’s response to other viruses like the flu by creating lasting memory in certain immune cells, a new study suggests.
Read More
NIH-backed research reveals diabetics taking metformin have a lower risk of developing long COVID or dying after infection compared to those on other diabetes medications.
Read More
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
Read More
Data from a post hoc analysis of a phase 2/3 study of oral opaganib in COVID-19 pneumonia showed a 62% reduction in mortality and a 21% improvement in time to room air.
Read More
Scientists have discovered a mutation in the SARS-CoV-2 spike protein that enhances the virus’ ability to infect the brain.
Read More
Adolescents were most likely to experience low energy/tiredness, while children were most likely to report headache.
Read More
Researchers have identified a potential treatment for the respiratory symptoms of long COVID by discovering an unknown cause of the condition within the lungs.
Read More
Six out of 23 common wildlife species showed signs of SARS-CoV-2 infections in an examination of animals in Virginia.
Read More
The risk of long COVID has decreased significantly over the course of the pandemic, and vaccination is a primary factor in reducing the risk of long COVID, according to research is published July 17 in The New England Journal of Medicine.
Read More
